"China and the World" Medical Forum will be held with CPhI China exhibition over the same period

Abstract: CPhI China exhibition supporting activities by the Chinese Medicines and Health Products Import and Export Chamber of Commerce (referred to as the "Health Insurance Association) the CPhI of UBM Conferences co-sponsored" China and the World Medical Forum will be held on 25-26 June 2013 inShanghai.

In order to ensure that Chinese exports to the U.S. and EU drug safety, effectiveness, and compliance with local standards, FDA, EDQM strengthen inspection of the Chinese pharmaceutical manufacturers, including: strengthening the inspection authority and function, at the same time, broadening the the scope of the inspection. For China's pharmaceutical companies, a real understanding of the concerns of the prosecutor where lessons, it is essential, and through on-site inspection case.

UBM Conferences co-sponsored by the Chinese Medicines and Health Products Import and Export Chamber of Commerce (referred to as the "Health Insurance Association) CPhI China and the World Medical Forum will be held on 25-26 June 2013 held in Shanghai. CPhI China Exhibition of supporting activities, a half day forum aims to provide a platform for communication and display professionals at home and abroad in the field of medicine, brought together the latest information of the pharmaceutical market and the development of the industry in many of the world's industry renowned Speakers vigorously support, explore the hot topics of the industry, to help businesses understand the latest market trends, regulations and policies, to find coping strategies and development path, and to promote international exchanges and cooperation.

The forum will focus on three modules discussed: the international regulatory environment for the export of drugs;, risk management and on-site inspections;, the WHO PQ certified with international procurement. Speakers currently confirmed to attend include: WHO pre-certification and drug quality and safety project technical officials, the person in charge of the Greater China region, the Bill & Melinda - Gates Foundation, the U.S. FDA site Attorney Matthew Casale, Delegation of the European Commission to China First Counsellor Dr Jerome LEPEINTRE, deputy director of the FDA office in China, Dr. Wang Gang, drug officials, Japan drugs and Medical devices Agency (PMDA) quality management Department officials late Sen Masatoshi.
                                                                              By Joseph